Back to trial details

Intake questionnaire

Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial

Applying to Weill Cornell Medicine · New York, New York

Answer a few short questions to share with the research team.

0 of 5 answered

1. Are you 18 years old or older?
2. Do you identify as female?
3. Have you been diagnosed with Breast Cancer?
4. Are you currently pregnant or breastfeeding?
5. Are you able to travel to New York for study visits?